Drug Shortage Report for FIBRISTAL
Report ID | 125019 |
Drug Identification Number | 02408163 |
Brand name | FIBRISTAL |
Common or Proper name | ulipristal acetate |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ULIPRISTAL ACETATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tablets |
ATC code | G03XB |
ATC description | OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-09-24 |
Estimated end date | |
Actual end date | 2020-09-24 |
Shortage status | Resolved |
Updated date | 2020-10-23 |
Company comments | Product recall |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-24 | English | Compare |
v2 | 2020-09-24 | English | Compare |
v3 | 2020-09-24 | French | Compare |
v4 | 2020-09-25 | English | Compare |
v5 | 2020-10-23 | English | Compare |
v6 | 2020-10-23 | French | Compare |
Showing 1 to 6 of 6